Understanding Development of Malnutrition in Hemodialysis Patients: A Narrative Review

Sharmela Sahathevan, Ban-Hock Khor, Hi-Ming Ng, Abdul Halim Abdul Gafor, Zulfitri Azuan Mat Daud, Denise Mafra, Tilakavati Karupaiah, Sharmela Sahathevan, Ban-Hock Khor, Hi-Ming Ng, Abdul Halim Abdul Gafor, Zulfitri Azuan Mat Daud, Denise Mafra, Tilakavati Karupaiah

Abstract

Hemodialysis (HD) majorly represents the global treatment option for patients with chronic kidney disease stage 5, and, despite advances in dialysis technology, these patients face a high risk of morbidity and mortality from malnutrition. We aimed to provide a novel view that malnutrition susceptibility in the global HD community is either or both of iatrogenic and of non-iatrogenic origins. This categorization of malnutrition origin clearly describes the role of each factor in contributing to malnutrition. Low dialysis adequacy resulting in uremia and metabolic acidosis and dialysis membranes and techniques, which incur greater amino-acid losses, are identified modifiable iatrogenic factors of malnutrition. Dietary inadequacy as per suboptimal energy and protein intakes due to poor appetite status, low diet quality, high diet monotony index, and/or psychosocial and financial barriers are modifiable non-iatrogenic factors implicated in malnutrition in these patients. These factors should be included in a comprehensive nutritional assessment for malnutrition risk. Leveraging the point of origin of malnutrition in dialysis patients is crucial for healthcare practitioners to enable personalized patient care, as well as determine country-specific malnutrition treatment strategies.

Keywords: hemodialysis; iatrogenic; malnutrition; non-iatrogenic factors.

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Etiology of malnutrition in dialysis patients.

References

    1. GBD Chronic Kidney Disease Collaboration Global, regional, and national burden of chronic kidney disease, 1990–2017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2020;395:709–733. doi: 10.1016/S0140-6736(20)30045-3.
    1. Liyanage T., Ninomiya T., Jha V., Neal B., Patrice H.M., Okpechi I., Zhao M., Lv J., Garg A.X., Knight J., et al. Worldwide access to treatment for end-stage kidney disease: A systematic review. Lancet. 2015;385:1975–1982. doi: 10.1016/S0140-6736(14)61601-9.
    1. National Kidney Foundation KDOQI Clinical Practice Guidelines for HD Adequacy: 2015 Update. Am. J. Kidney Dis. 2015;66:884–930. doi: 10.1053/j.ajkd.2015.07.015.
    1. Carrero J.J., Thomas F., Nagy K., Arogundade F., Avesani C.M., Chan M., Chmielewski M., Cordeiro A.C., Espinosa-Cuevas A., Fiaccadori E., et al. Global Prevalence of Protein-Energy Wasting in Kidney Disease: A Meta-analysis of Contemporary Observational Studies from the International Society of Renal Nutrition and Metabolism. J. Ren. Nutr. 2018;28:380–392. doi: 10.1053/j.jrn.2018.08.006.
    1. Takahashi H., Inoue K., Shimizu K., Hiraga K., Takahashi E., Otaki K., Yoshikawa T., Furuta K., Tokunaga C., Sakakibara T., et al. on behalf of the Tokai Renal Nutrition Study Group. Comparison of Nutritional Risk Scores for Predicting Mortality in Japanese Chronic Hemodialysis Patients. J. Ren. Nutr. 2017;27:201–206. doi: 10.1053/j.jrn.2016.12.005.
    1. Toledo F., Antunes A., Vannini F.C.D., Silveira L.V.A., Martin L.C., Barretti P., Caramori J.C.T. Validity of malnutrition scores for predicting mortality in chronic hemodialysis patients. Int. Urol. Nephrol. 2013;45:1747–1752. doi: 10.1007/s11255-013-0482-3.
    1. Uy M.C., Lim-Alba R., Chua E. Association of Dialysis Malnutrition Score with Hypoglycemia and Quality of Life among Patients with Diabetes on Maintenance Hemodialysis. J. ASEAN Fed. Endocr. Soc. 2018;33:137–145. doi: 10.15605/jafes.033.02.05.
    1. Carrero J.J., Stenvinkel P., Cuppari L., Ikizler T.A., Kalantar-Zadeh K., Kaysen G., Mitch W.E., Price S.R., Wanner C., Wang A.Y., et al. Etiology of the protein-energy wasting syndrome in chronic kidney disease: A consensus statement from the International Society of Renal Nutrition and Metabolism (ISRNM) J. Ren. Nutr. 2013;23:77–90. doi: 10.1053/j.jrn.2013.01.001.
    1. Tan R., Long J., Fang S., Mai H., Lu W., Liu Y., Wei J., Yan F. Nutritional Risk Screening in patients with chronic kidney disease. Asia Pac. J. Clin. Nutr. 2016;25:249–256.
    1. Vanholder R., Fouque D., Glorieux G., Heine G.H., Kanbay M., Mallamaci F., Massy Z.A., Ortiz A., Rossignol P., Wiecek A., et al. For the European Renal Association European Dialysis and Transplant Association (ERA-EDTA) European Renal and Cardiovascular Medicine (EURECA-m) working group. Clinical management of the uraemic syndrome in chronic kidney disease. Lancet Diabetes Endocrinol. 2016;4:360–373. doi: 10.1016/S2213-8587(16)00033-4.
    1. Caetano C., Valente A., Oliveira T., Garagarza C. Body composition and mortality predictors in hemodialysis patients. J. Ren. Nutr. 2016;26:81–86. doi: 10.1053/j.jrn.2015.10.005.
    1. Fouque D., Kalantar-Zadeh K., Kopple J. A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int. 2008;73:391–398. doi: 10.1038/sj.ki.5002585.
    1. Bonilla-Palomas J.L., Gámez-López A.L., Anguita-Sánchez M.P., Castillo-Domínguez J.C., García-Fuertes D., Crespin-Crespin M., López-Granados A., Suárez de Lezo J. Impact of malnutrition on long-term mortality in hospitalized patients with heart failure. Rev. Esp. Cardiol. 2011;64:752–758. doi: 10.1016/j.recesp.2011.03.009.
    1. Tuegel C., Bansal N. Heart failure in patients with kidney disease. Heart. 2017;103:1848–1853. doi: 10.1136/heartjnl-2016-310794.
    1. Grossniklaus D.A., O’Brien M.C., Clark P.C., Dunbar S.B. Nutrient intake in heart failure patients. J. Cardiovasc. Nurs. 2008;23:357–363. doi: 10.1097/01.JCN.0000317433.52210.e0.
    1. Naini A.E., Karbalaie A., Abedini M., Askari G., Moeinzadeh F. Comparison of malnutrition in hemodialysis and peritoneal dialysis patients and its relationship with echocardiographic findings. J. Res. Med. Sci. 2016;21:78. doi: 10.4103/1735-1995.189695.
    1. Spatola L., Finazzi S., Calvetta A., Reggiani F., Morenghi E., Santostasi S., Angelini C., Badalamenti S., Mugnai G. Subjective Global Assessment-Dialysis Malnutrition Score and cardiovascular risk in hemodialysis patients: An observational cohort study. J. Nephrol. 2018;31:757–765. doi: 10.1007/s40620-018-0505-3.
    1. Van der Tol A., Lameire N., Morton R.L., Biesen M.V., Vanholder R. An International Analysis of Dialysis Services Reimbursement. Clin. J. Am. Soc. Nephrol. 2019;14:83–94. doi: 10.2215/CJN.08150718.
    1. Robinson B.M., Zhang J., Morgenstern H., Bradbury B.D., Ng L.J., McCullough K.P., Gillespie B.W., Hakim R., Rayner H., Fort J., et al. Worldwide, mortality risk is high soon after initiation of hemodialysis. Kidney Int. 2013;85:158–165. doi: 10.1038/ki.2013.252.
    1. Lukowsky L.R., Kheifets L., Arah O.A., Nissenson A.R., Kalantar-Zadeh K. Patterns and Predictors of Early Mortality in Incident Hemodialysis Patients: New Insights. Am. J. Nephrol. 2012;35:548–558. doi: 10.1159/000338673.
    1. Goldstein M., Yassa T., Dacouris N., McFarlane P. Multidisciplinary Predialysis Care and Morbidity and Mortality of Patients on Dialysis. Am. J. Kidney Dis. 2004;44:706–714. doi: 10.1016/S0272-6386(04)00940-0.
    1. McQuillan R., Trpeski L., Fenton S., Lok C.E. Modifiable Risk Factors for Early Mortality on Hemodialysis. Int. J. Nephrol. 2012;2012:435736. doi: 10.1155/2012/435736.
    1. Slinin Y., Guo H., Gilbertson D.T., Mau L.W., Ensrud K., Collins A.J., Ishani A. Prehemodialysis Care by Dietitians and First-Year Mortality After Initiation of Hemodialysis. Am. J. Kidney Dis. 2011;58:583–590. doi: 10.1053/j.ajkd.2011.03.032.
    1. Ledebo I., Kessler M., van Biesen W., Wanner C., Wiecek A., Prichard S., Argilés A., Ritz E. Initiation of dialysis: Opinions from an international survey: Report on the dialysis opinion symposium at the ERA-EDTA Congress, 18 September 2000, Nice. Nephrol. Dial. Transplant. 2001;16:1132–1138. doi: 10.1093/ndt/16.6.1132.
    1. van de Luijtgaarden M.W., Noordzij M., Tomson C., Couchoud C., Cancarini G., Ansell D., Bos W.J., Dekker F.W., Gorriz J.L., Iatrou C., et al. Factors Influencing the Decision to Start Renal Replacement Therapy: Results of a Survey Among European Nephrologists. Am. J. Kidney Dis. 2012;60:940–948. doi: 10.1053/j.ajkd.2012.07.015.
    1. Rosansky S.J., Cancarini G., Clark W.F., Eggers P., Germaine M., Glassock R., Goldfarb D.S., Harris D., Hwang S.J., Imperial E.B., et al. Dialysis Initiation: What’s the Rush? Semin. Dial. 2013;26:650–657. doi: 10.1111/sdi.12134.
    1. Nesrallah G.E., Mustafa R.A., Clark W.F., Bass A., Barnieh L., Hemmelgarn B.R., Klarenbach S., Quinn R.R., Hiremath S., Ravani P., et al. Canadian Society of Nephrology 2014 clinical practice guideline for timing the initiation of chronic dialysis. CMAJ. 2014;186:112–117. doi: 10.1503/cmaj.130363.
    1. Kelly J., Stanley M., Harris D. Caring for Australians with Renal Impairment (CARI). The CARI guidelines. Acceptance into dialysis guidelines. Nephrology. 2005;10:S46–S60. doi: 10.1111/j.1440-1797.2005.00486_1.x.
    1. Carrero J.J., Nakashima A., Qureshi A.R., Lindholm B., Heimburger O., Barany P., Stenvinkel P. Protein-energy wasting modifies the association of ghrelin with inflammation, leptin, and mortality in hemodialysis patients. Kidney Int. 2011;79:749–756. doi: 10.1038/ki.2010.487.
    1. Gama-Axelsson T., Heimb€urger O., Stenvinkel P., Barany P., Lindholm B., Qureshi A.R. Serum albumin as predictor of nutritional status in patients with ESRD. Clin. J. Am. Soc. Nephrol. 2012;7:1446–1453. doi: 10.2215/CJN.10251011.
    1. Therrien M., Byham-Gray L., Beto J. A Review of Dietary Intake Studies in Maintenance Dialysis Patients. J. Ren. Nutr. 2015;25:329–338. doi: 10.1053/j.jrn.2014.11.001.
    1. Kwon Y.E., Yoon C.Y., Han I.M., Han S.G., Park K.S., Lee M.J., Park J.T., Han S.H., Yoo T.H., Kim Y.L., et al. Change of Nutritional Status Assessed Using Subjective Global Assessment Is Associated with All-Cause Mortality in Incident Dialysis Patients. Medicine. 2016;95:e2714. doi: 10.1097/MD.0000000000002714.
    1. Araujo L.C., Kamimira M.A., Draibe S.A., Canziani M.E.F., Manfredi S.R., Avesani C.M., Sesso R., Cuppari L. Nutritional Parameters and Mortality in Incident Hemodialysis Patients. J. Ren. Nutr. 2016;16:27–35. doi: 10.1053/j.jrn.2005.10.003.
    1. Bradbury B.D., Fissell R.B., Albert J.M., Anthony M.S., Critchlow C.W., Pisoni R.L., Port F.K., Gillespie B.W. Predictors of Early Mortality among Incident US Hemodialysis Patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS) Clin. J. Am. Soc. Nephrol. 2007;2:89–99. doi: 10.2215/CJN.01170905.
    1. Murray D.P., Young L., Waller J., Wright S., Colombo R., Baer S., Spearman V., Garcia-Torres R., Williams K., Kheda M., et al. Is Dietary Protein Intake Predictive of One-Year Mortality in Dialysis Patients? Am. J. Med. Sci. 2018;356:234–243. doi: 10.1016/j.amjms.2018.06.010.
    1. Pifer T.B., Mccullough K.P., Port F.K., Goodkin D.A., Maroni B.J., Held P.J., Young E.W. Mortality risk in hemodialysis patients and changes in nutritional indicators: DOPPS. Kidney Int. 2002;62:2238–2245. doi: 10.1046/j.1523-1755.2002.00658.x.
    1. Dekker M.J.E., Marcelli D., Canaud B., Konings C.J.A.M., Leunissen K.M., Levin N.W., Carioni P., Maheshwari V., Raimann J.G., van der Sande F.M., et al. Unraveling the relationship between mortality, hyponatremia, inflammation and malnutrition in hemodialysis patients: Results from the international MONDO initiative. Eur. J. Clin. Nutr. 2016;70:779–784. doi: 10.1038/ejcn.2016.49.
    1. Rosenberger J., Kissova V., Majernikova M., Straussova Z., Boldizsar J. Body composition monitor assessing malnutrition in the hemodialysis population independently predicts mortality. J. Ren. Nutr. 2014;24:172–176. doi: 10.1053/j.jrn.2014.01.002.
    1. Chertow G.M., Goldstein-Fuchs D.J., Lazarus J.M., Kaysen G.A. Prealbumin, mortality and cause-specific hospitalization in hemodialysis patients. Kidney Int. 2005;68:2794–2800. doi: 10.1111/j.1523-1755.2005.00751.x.
    1. Butterworth C.E. The skeleton in the hospital closet. Nutr. Today. 1974;9:4–8. doi: 10.1097/00017285-197403000-00001.
    1. Van Gelder M., Abrahams A.C., Joles J.A., Kaysen G.A., Gerritsen K. Albumin handling in different hemodialysis modalities. Nephrol. Dial. Transplant. 2018;33:906–913. doi: 10.1093/ndt/gfx191.
    1. Wolfson M., Jones M.R., Kopple J.D. Amino acid losses during hemodialysis with infusion of amino acids and glucose. Kidney Int. 1982;21:500–506. doi: 10.1038/ki.1982.52.
    1. Ikizler T.A., Flakoli P.J., Parker R.A., Hakim R.M. Amino acid and albumin losses during hemodialysis. Kidney Int. 1994;46:830–837. doi: 10.1038/ki.1994.339.
    1. Salame C., Eaton S., Grimble G., Davenport A. Protein Losses and Urea Nitrogen Underestimate Total Nitrogen Losses in Peritoneal Dialysis and Hemodialysis Patients. J. Ren. Nutr. 2018;28:317–323. doi: 10.1053/j.jrn.2018.01.016.
    1. Ikizler T.A., Pupim L.B., Brouillette J.R., Levenhagen D.K., Farmer K., Hakim R.M., Flakoll P.J. Hemodialysis stimulates muscle and whole body protein loss and alters substrate oxidation. Am. J. Physiol.-Endocrinol. Metab. 2002;282:E107–E116. doi: 10.1152/ajpendo.2002.282.1.E107.
    1. Murtas S., Aquilani R., Deiana M.L. Differences in amino acid loss between high-efficiency hemodialysis and post-dilution and pre-dilution hemodiafiltration using high convection volume exchange-A new metabolic scenario? A pilot study. J. Ren. Nutr. 2019;29:126–135. doi: 10.1053/j.jrn.2018.07.005.
    1. Pupim L.B., Flakoll P.J., Brouillette J.R., Levenhagen D.K., Hakim R.M., Ikizler T.A. Intradialytic parenteral nutrition improves protein and energy homeostasis in chronic hemodialysis patients. J. Clin. Investig. 2002;110:483–492. doi: 10.1172/JCI0215449.
    1. Kohlová M., Amorim C.G., Araújo A., Santos-Silva A., Solich P., Montenegro M.C.B.S.M. The biocompatibility and bioactivity of hemodialysis membranes: Their impact in end-stage renal disease. J. Artif. Organs. 2019;22:14–28. doi: 10.1007/s10047-018-1059-9.
    1. Krieter D.H., Canaud B. High permeability of dialysis membranes: What is the limit of albumin loss? Nephrol. Dial. Transplant. 2003;18:651–654. doi: 10.1093/ndt/gfg054.
    1. Fouque D., Pelletier S., Mafra D., Chauveau P. Nutrition and chronic kidney disease. Kidney Int. 2011;80:348–357. doi: 10.1038/ki.2011.118.
    1. Honeich N.A., Woffindin C., Matthews J.N.S., Goldfinch M.E., Turnbull J. Clinical comparison of high-flux cellulose acetate and synthetic membranes. Nephrol. Dial. Transplant. 1994;9:60–66.
    1. Gil H.W., Yang J.O., Lee E.Y., Lee E.M., Choi J.S., Hong S.Y. The Effect of Dialysis Membrane Flux on Amino Acid Loss in Hemodialysis Patients. J. Korean Med. Sci. 2007;22:598–603. doi: 10.3346/jkms.2007.22.4.598.
    1. Kirsch A.H., Lyko R., Nilsson L.G., Beck W., Amdahl M., Lechner P., Schneider A., Wanner C., Rosenkranz A.R., Krieter D.H. Performance of hemodialysis with novel medium cut-off dialyzers. Nephrol. Dial. Transplant. 2017;32:165–172. doi: 10.1093/ndt/gfw310.
    1. Meert N., Eloot S., Schepers E., Lemke H.D., Dhondt A., Glorieux G., Landschoot M.V., Waterloos M.A., Vanholder R. Comparison of removal capacity of two consecutive generations of high-flux dialysers during different treatment modalities. Nephrol. Dial. Transplant. 2011;26:2624–2630. doi: 10.1093/ndt/gfq803.
    1. Scribner B.H. A personalized history of chronic hemodialysis. Am. J. Kidney Dis. 1990;16:511–519. doi: 10.1016/S0272-6386(12)81034-1.
    1. Fagugli R.M., De Smet R., Buoncristiani U., Lameire N., Vanholder R. Behavior of Non–Protein-Bound and Protein-Bound Uremic Solutes During Daily Hemodialysis. Am. J. Kidney Dis. 2002;40:339–347. doi: 10.1053/ajkd.2002.34518.
    1. Florens N., Juillard L. Large Middle Molecule and Albumin Removal: Why Should We Not Rest on Our Laurels? Contrib. Nephrol. 2017;191:178–187.
    1. Krieter D.H., Hackl A., Rodriguez A., Chenine L., Moragues H.L., Lemke H.D., Wanner C., Canaud B. Protein-bound uraemic toxin removal in haemodialysis and post-dilution haemodiafiltration. Nephrol. Dial. Transplant. 2010;25:212–218. doi: 10.1093/ndt/gfp437.
    1. Locatelli F., Martin-Malo A., Hannedouche T. Effect of membrane permeability on survival of hemodialysis patients. J. Am. Soc. Nephrol. 2009;20:645–654. doi: 10.1681/ASN.2008060590.
    1. Tiranathanagul K., Praditpornsilpa K., Katavetin P., Srisawat N., Townamchai N., Susantitaphong P., Tungsanga K., Eiam-Ong S. On-line Hemodiafiltration in Southeast Asia: A Three-year Prospective Study of a Single Center. Ther. Apher. Dial. 2009;13:56–62. doi: 10.1111/j.1744-9987.2009.00654.x.
    1. Boschetti-de-Fierro A., Beck W., Hildwein H., Krause B., Storr M., Zweigart C. Membrane Innovation in Dialysis. Contrib. Nephrol. 2017;191:100–114.
    1. Slinin Y., Greer N., Ishani A., MacDonald R., Olson C., Rutks I., Wilt T.J. Timing of Dialysis Initiation, Duration and Frequency of Hemodialysis Sessions, and Membrane Flux: A Systematic Review for a KDOQI Clinical Practice Guideline. Am. J. Kidney Dis. 2015;66:823–836. doi: 10.1053/j.ajkd.2014.11.031.
    1. Kneis C., Beck W., Boenisch O., Klefisch F., Deppisch R., Zickler D., Schindler R. Elimination of Middle-Sized Uremic Solutes with High-Flux and High-Cut-Off Membranes: A Randomized in vivo Study. Blood Purif. 2013;36:287–294. doi: 10.1159/000356224.
    1. Gondouin B., Hutchison C.A. High Cut-off Dialysis Membranes: Current Uses and Future Potential. Adv. Chronic Kidney Dis. 2011;18:180–187. doi: 10.1053/j.ackd.2011.02.006.
    1. Girndt M., Fiedler R., Martus P., Pawlak M., Storr M., Bohler T., Glomb M.A., Liehr K., Henning C., Templin M., et al. High cut-off dialysis in chronic haemodialysis patients. Eur. J. Clin. Investig. 2015;45:1333–1340. doi: 10.1111/eci.12559.
    1. Zickler D., Schindler R., Willy K., Martus P., Pawlak M., Storr M., Hulko M., Boehler T., Glomb M.A., Liehr K., et al. Medium Cut-Off (MCO) Membranes Reduce Inflammation in Chronic Dialysis Patients: A Randomized Controlled Clinical Trial. PLoS ONE. 2017;12:e0169024. doi: 10.1371/journal.pone.0169024.
    1. Upadhyay A., Jaber B.L. Reuse and Biocompatibility of Hemodialysis Membranes: Clinically Relevant? Semin. Dial. 2017;30:121–124. doi: 10.1111/sdi.12574.
    1. Upadhyay A. Dialyzer reuse: Is it safe and worth it? Braz. J. Nephrol. 2019;41:312–314. doi: 10.1590/2175-8239-jbn-2019-0134.
    1. Lacson E., Jr., Lazarus J.M. Dialyzer best practice: Single use or reuse? Semin. Dial. 2006;19:120–128. doi: 10.1111/j.1525-139X.2006.00137.x.
    1. Ribeiro I.C., Roza N.A.V., Duarte D.A., Guadagnini D., Elias R.M., de Oliveira R.B. Clinical and microbiological effects of dialyzers reuse in hemodialysis patients. Braz. J. Nephrol. 2019;41:384–392. doi: 10.1590/2175-8239-jbn-2018-0151.
    1. Argyropoulos C., Roumelioti M.E., Sattar A., Kellum J.A., Weissfeld L., Unruh M.L. Dialyzer Reuse and Outcomes of High Flux Dialysis. PLoS ONE. 2015;10:e0129575. doi: 10.1371/journal.pone.0129575.
    1. Hamid A., Dhrolia M.F., Imtiaz S., Qureshi R., Ahmad A. Comparison of Adequacy of Dialysis between Single-use and Reused Hemodialyzers in Patients on Maintenance Hemodialysis. J. Coll. Physicians Surg. Pak. 2019;29:720–723. doi: 10.29271/jcpsp.2019.08.720.
    1. Jofre R., Rodriguez-Benitez P., Lopez-Gomez J.M., Perez-Garcia R. Inflammatory Syndrome in Patients on Hemodialysis. J. Am. Soc. Nephrol. 2006;17:S274–S280. doi: 10.1681/ASN.2006080926.
    1. Poppelaars F., Faria B., da Costa M.G., Franssen C.F.M., van Son W.J., Berger S.P., Daha M.R., Seelen M.A. The Complement System in Dialysis: A Forgotten Story? Front. Immunol. 2018;9:71. doi: 10.3389/fimmu.2018.00071.
    1. Abe M., Hamano T., Wada A., Nakai S., Masakane I. Effect of dialyzer membrane materials on survival in chronic hemodialysis patients: Results from the annual survey of the Japanese Nationwide Dialysis Registry. PLoS ONE. 2017;12:e0184424. doi: 10.1371/journal.pone.0184424.
    1. Wong J., Vilar E., Farrington K. Endotoxemia in End-Stage Kidney Disease. Semin. Dial. 2014;28:59–67. doi: 10.1111/sdi.12280.
    1. Gagliardi G.M., Rossi S., Condino F., Mancuso D., Greco F., Tenuta R., Savino O., Bonofiglio R., Domma F., Latorre G. Malnutrition, infection and arteriovenous fistula failure: Is there a link? J. Vasc. Access. 2011;12:57–62. doi: 10.5301/JVA.2010.5831.
    1. Dukkipati R., Molnar M.Z., Park J., Jing J., Kovesdy C.P., Kajani R., Kalantar-Zadeh K. Association of Vascular Access Type with Inflammatory Marker Levels in Maintenance Hemodialysis Patients. Semin. Dial. 2014;27:415–423. doi: 10.1111/sdi.12146.
    1. Zavacka M., Zelko A., Madarasova Geckova A., Majernikova M., Pobehova J., Zavacky P. Vascular access as a survival factor for the haemodialysis population: A retrospective study. Int. Angiol. 2020 doi: 10.23736/S0392-9590.20.04401-6.
    1. Debska-Slizien A., Malgorzewicz S., Dudziak M., Ksiazek A., Sulowicz W., Grzeszczak W. Cardiovascular risk in patients undergoing maintenance hemodialysis with Helixone(R) membrane: A multicenter randomized study. Pol. Arch. Med. Wewn. 2014;124:593–598.
    1. Movilli E., Camerini C., Gaggia P. Total convection affects serum beta2 microglobulin and C-reactive protein but not erythropoietin requirement following post-dilutional hemodiafiltration. Am. J. Nephrol. 2015;41:494–501. doi: 10.1159/000437171.
    1. Galli F., Benedetti S., Floridi A., Canestrari F., Piroddi M., Buoncristiani E., Buoncristiani U. Glycoxidation and inflammatory markers in patients on treatment with PMMA-based protein-leaking dialyzers. Kidney Int. 2005;67:750–759. doi: 10.1111/j.1523-1755.2005.67138.x.
    1. Glorieux G., Neirynk N., Veys N., Vanholder R. Dialysis water and fluid purity: More than endotoxin. Nephrol. Dial. Transplant. 2012;27:4010–4021. doi: 10.1093/ndt/gfs306.
    1. Heumann D., Roger T. Initial responses to endotoxins and Gram-negative bacteria. Clin. Chim. Acta. 2002;323:59–72. doi: 10.1016/S0009-8981(02)00180-8.
    1. Bossola M., Stasio E.D., Sanguinetti M., Posteraro B., Antocicco M., Pepe G., Mello E., Bugli F., Vulpio C. Serum Endotoxin Activity Measured with Endotoxin Activity Assay Is Associated with Serum Interleukin-6 Levels in Patients on Chronic Hemodialysis. Blood Purif. 2016;42:294–300. doi: 10.1159/000449096.
    1. El-Koraie A.F., Naga Y.S., Farahat N.G., Hazzah W.A. Endotoxins and inflammation in hemodialysis patients. Hemodial. Int. 2013;17:359–365. doi: 10.1111/hdi.12007.
    1. Horl W.H. Hemodialysis Membranes: Interleukins, biocompatibility, and middle molecules. J. Am. Soc. Nephrol. 2002;13:62–71.
    1. Vanholder R., Pletinck A., Schepers E., Glorieux G. Biochemical and Clinical Impact of Organic Uremic Retention Solutes: A Comprehensive Update. Toxins. 2018;10:33. doi: 10.3390/toxins10010033.
    1. Biswas S.K. Does the Interdependence between Oxidative Stress and Inflammation Explain the Antioxidant Paradox? Oxid. Med. Cell Longev. 2016;2016:5698931. doi: 10.1155/2016/5698931.
    1. Sanz A.B., Sanchez-Nino M.D., Ramos A.M., Moreno J.A., Santamaria B., Ruiz-Ortega M., Egido J., Ortiz A. NF-κB in Renal Inflammation. J. Am. Soc. Nephrol. 2010;21:1254–1262. doi: 10.1681/ASN.2010020218.
    1. Liakopoulos V., Roumeliotis S., Zarogiannis S., Eleftheriadis T., Mertens P.R. Oxidative stress in hemodialysis: Causative mechanisms, clinical implications, and possible therapeutic interventions. Semin. Dial. 2019;32:58–71. doi: 10.1111/sdi.12745.
    1. Navarro-García J.A., Rodríguez-Sánchez E., Aceves-Ripoll J., Abarca-Zabalía J., Susmozas-Sánchez A., González Lafuente L., Bada-Bosch T., Hernández E., Mérida-Herrero E., Praga M., et al. Oxidative Status before and after Renal Replacement Therapy: Differences between Conventional High Flux Hemodialysis and on-Line Hemodiafiltration. Nutrients. 2019;11:2809
    1. Fatonah S., Sulchan M., Sofro M.A.U. Macronutrients, micronutrients intake and inflammation in hemodialysis patients. Potravin. Slovak J. Food Sci. 2019;13:891–897. doi: 10.5219/1193.
    1. Barroso C.F., Pires L.V., Santos L.B., Henriques G.S., Pessoa P.P., de Araújo G.N., de Araújo C.O.D., Oliveira C.M.C., Maia C.S.C. Selenium Nutritional Status and Glutathione Peroxidase Activity and Its Relationship with Hemodialysis Time in Individuals Living in a Brazilian Region with Selenium-Rich Soil. Biol. Trace Elem. Res. 2020 doi: 10.1007/s12011-020-02388-1.
    1. Silva R.E., Simões-E-Silva A.C., Miranda A.S., Justino P.B.I., Brigagão M.R.P.L., Moraes G.O.I., Gonçalves R.V., Novaes R.D. Potential Role of Nutrient Intake and Malnutrition as Predictors of Uremic Oxidative Toxicity in Patients with End-Stage Renal Disease. Oxid. Med. Cell. Longev. 2019;2019:7463412. doi: 10.1155/2019/7463412.
    1. Viramontes Hörner D., Selby N.M., Taal M.W. The Association of Nutritional Factors and Skin Autofluorescence in Persons Receiving Hemodialysis. J. Ren. Nutr. 2019;29:149–155. doi: 10.1053/j.jrn.2018.07.004.
    1. Almeida S.G., Veiga J.P., Arruda S.F., Neves C.F., Siqueira E.M. The association of markers of oxidative-inflammatory status with malnutrition in hemodialysis patients with serum ferritin lower than 500 ng/mL. J. Bras. Nefrol. 2013;35:6–12. doi: 10.5935/01012800.20130002.
    1. Kalantar-Zadeh K., Ikizler T.A., Block G., Avram M.M., Kopple J.D. Malnutrition-inflammation complex syndrome in dialysis patients: Causes and consequences. Am. J. Kidney Dis. 2003;42:864–881. doi: 10.1016/j.ajkd.2003.07.016.
    1. Rippe B., Öberg C.M. Albumin Turnover in Peritoneal and Hemodialysis. Semin. Dial. 2006;29:458–462. doi: 10.1111/sdi.12534.
    1. Oliveira C.M.C., Kubrusly M., Lima A.T., Torres D.M., Cavalcante N.M.R., Jeronimo A.L.C., Oliveira T.C.B. Correlation Between Nutritional Markers and Appetite Self-Assessments in Hemodialysis Patients. J. Ren. Nutr. 2015;25:301–307. doi: 10.1053/j.jrn.2014.09.006.
    1. Essadik R., Msaad R., Lebrazi H., Taki H., Tahri E.H., Kettani A., Madkouri G., Ramdani B., Saïle R. Assessing the prevalence of protein-energy wasting in haemodialysis patients: A cross-sectional monocentric study. Nephrol. Ther. 2017;13:537–543. doi: 10.1016/j.nephro.2017.02.013.
    1. Eloot S., Biesen W.V., Dhondt A., de Wynkele H.V., Glorieux G., Verdonck P., Vanholder R. Impact of hemodialysis duration on the removal of uremic retention solutes. Kidney Int. 2008;73:765–770. doi: 10.1038/sj.ki.5002750.
    1. Stegmayr B. Dialysis Procedures Alter Metabolic Conditions. Nutrients. 2017;9:548. doi: 10.3390/nu9060548.
    1. Depner T.A. Uremic toxicity: Urea and beyond. Semin. Dial. 2008;14:246–251. doi: 10.1046/j.1525-139X.2001.00072.x.
    1. Jansen J., Jankowski J., Gajjala P.R., Wetzels J.F.M., Masereeuw R. Disposition and clinical implications of protein-bound uremic toxins. Clin. Sci. 2017;131:1631–1647. doi: 10.1042/CS20160191.
    1. Deltombe O., de Loor H., Glorieux G., Dhondt A., Biesen W.V., Meijers B., Eloot S. Exploring binding characteristics and the related competition of different protein-bound uremic toxins. Biochimie. 2017;139:20–26. doi: 10.1016/j.biochi.2017.05.010.
    1. Kuhlmann M.K., Kotanko P., Levin N.W. Hemodialysis: Outcome and Adequacy. In: Johnson R.J., Feehally J., Floege J., editors. Comprehensive Clinical Nephrology. Elsevier; Philadelphia, PA, USA: 2015. pp. 1075–1083.
    1. Yu X. The Evolving Patterns of Uremia: Unmet Clinical Needs in Dialysis. Contrib. Nephrol. 2017;191:1–7.
    1. Rocco M.V., Dwyer J.T., Larive B., Greene T., Cockram D.B., Chumlea W.C., Kusek J.W., Leung J., Burrowes J.D., Mcleroy S.L., et al. The effect of dialysis dose and membrane flux on nutritional parameters in hemodialysis patients: Results of the HEMO Study. Kidney Int. 2004;65:2321–2334. doi: 10.1111/j.1523-1755.2004.00647.x.
    1. Jones C.B., Bargman M. Should we look beyond Kt/V urea in assessing dialysis adequacy? Semin. Dial. 2018;31:420–429. doi: 10.1111/sdi.12684.
    1. Bossola M., Muscaritoli M., Tazza L., Giungi S., Tortorelli A., Fanelli F.R., Luciani G. Malnutrition in Hemodialysis Patients: What Therapy? Am. J. Kidney Dis. 2005;46:371–386. doi: 10.1053/j.ajkd.2005.05.031.
    1. Carrero J.J., Aguilera A., Stenvinkel P., Gil F., Selgas R., Lindhlm B. Appetite Discorders in Uremia. J. Ren. Nutr. 2008;18:107–112. doi: 10.1053/j.jrn.2007.10.022.
    1. Daugirdas J.T., Greene T., Chertow G.M., Depner T.A. Can rescaling dose with 6 of dialysis to body surface area in the HEMO study explain the different responses to dose in women versus men? Clin. J. Am. Soc. Nephrol. 2010;5:1628–1636. doi: 10.2215/CJN.02350310.
    1. Rashidi A.A., Soleimani A.R., Nikoueinejad H., Sarbolouki S. The Evaluation of Increase in Hemodialysis Frequency on C-Reactive Protein Levels and Nutritional Status. Acta Med. Iran. 2013;51:119–124.
    1. Chazot C., Jean G. The advantages and challenges of increasing the duration and frequency of maintenance dialysis sessions. Nature Clin. Pract. Nephrol. 2009;5:34–44. doi: 10.1038/ncpneph0979.
    1. Jha V. Current status of end-stage renal disease care in India and Pakistan. Kidney Inter Suppl. 2013;3:157–160. doi: 10.1038/kisup.2013.3.
    1. Jha V. End-stage renal care in developing countries: The India experience. Ren. Fail. 2004;26:201–208. doi: 10.1081/JDI-120039516.
    1. Chauhan R., Mendonca S. Adequacy of twice weekly hemodialysis in end stage renal disease patients at a tertiary care dialysis centre. Indian J. Nephrol. 2015;25:329–333. doi: 10.4103/0971-4065.151762.
    1. Daugirdas J.T. Hemodialysis Treatment Time: As Important as it seems? Semin. Dial. 2017;30:93–98. doi: 10.1111/sdi.12575.
    1. Torigoe A., Sato E., Mori T., Ieiri N., Takahashi C., Ishida Y., Hotta O., Ito S. Comparisons of amino acids, body constituents and antioxidative response between long-time HD and normal HD. Hemodial. Int. 2016;20:S17–S24. doi: 10.1111/hdi.12462.
    1. Tentori F., Zhang J., Li Y., Karaboyas A., Kerr P., Saran R. Longer dialysis session length is associated with better intermediate outcomes and survival among patients on in-center three times per week hemodialysis: Results from the Dialysis Outcomes and Practice Patterns Study (DOPPS) Nephrol. Dial. Transplant. 2012;27:4180–4188. doi: 10.1093/ndt/gfs021.
    1. Rezende L.R., de Souza P.B., Pereira G.R.M., Lugon J.R. Metabolic acidosis in hemodialysis patients: A review. Braz. J. Nephrol. 2017;39:305–311. doi: 10.5935/0101-2800.20170053.
    1. Soudan K., Ricanati E.S., Leon J.B., Sehgal A.R. Determinants of metabolic acidosis among hemodialysis patients. Hemodial. Int. 2006;10:209–214. doi: 10.1111/j.1542-4758.2006.00096.x.
    1. Abramowitz M.K. Bicarbonate Balance and Prescription in ESRD. J. Am. Soc. Nephrol. 2017;28:726–734. doi: 10.1681/ASN.2016070780.
    1. Gennari F.J. Acid-base considerations in end stage renal disease. In: Henrich W.L., editor. Principles and Practice of Dialysis. Lippincott Williams & Wilkins; Philadelphia, PA, USA: 2004. pp. 393–407.
    1. Ikizler T.A., Burrowes J.D., Byham-Gray L.D., Campbell K.L., Carrero J.J., Chan W., Fouque D., Friedman A.N., Ghaddar S., Goldstein-Fuchs D.J., et al. KDOQI Clinical Practice Guideline for Nutrition in CKD: 2020 Update. Am J Kidney Dis. 2020;3:S1–S107. doi: 10.1053/j.ajkd.2020.05.006.
    1. Thornley-Brown D., Saha M. Dialysate content and risk of sudden cardiac death. Curr. Opin. Nephrol. Hypertens. 2015;24:557–562. doi: 10.1097/MNH.0000000000000177.
    1. Mehrotra R., Kopple J.D., Wolfsin M. Metabolic acidosis in maintenance dialysis patients: Clinical considerations. Kidney Int. 2003;64:S13–S25. doi: 10.1046/j.1523-1755.2003.08802.x.
    1. Ikizler T.A., Cano N.J., Franch H., Fouque D., Himmelfarb J., Kalantar-Zadeh K., Kuhlmann M.K., Stenvinkel P., TerWee P., Teta D., et al. Prevention and treatment of protein energy wasting in chronic kidney disease patients: A consensus statement by the International Society of Renal Nutrition and Metabolism. Kidney Int. 2013;84:1096–1107. doi: 10.1038/ki.2013.147.
    1. Stenvinkel P., Carrero J.J., von Walden F., Ikizler T.A., Nader G.A. Muscle wasting in end-stage renal disease promulgates premature death: Established, emerging and potential novel treatment strategies. Nephrol. Dial. Transplant. 2016;31:1070–1077. doi: 10.1093/ndt/gfv122.
    1. DeFronzo R.A., Tobin J.D., Rowe J.W., Andres R. Glucose intolerance in uremia. Quantification of pancreatic beta cell sensitivity to glucose and tissue sensitivity to insulin. J. Clin. Investig. 1978;62:425–435. doi: 10.1172/JCI109144.
    1. Raj S., Scott D.R., Nguyen T., Sachs G., Kraut J.A. Acid stress increases gene expression of proinflammatory cytokines in Madin-Darby canine kidney cells. Am. J. Physiol. Renal. Physiol. 2013;304:F41–F48. doi: 10.1152/ajprenal.00128.2012.
    1. Kellum J.A., Song M., Li J. Lactic and hydrochloric acids induce different patterns of inflammatory response in LPS-stimulated RAW 264.7 cells. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2004;286:R686–R692. doi: 10.1152/ajpregu.00564.2003.
    1. Soleymanian T., Ghods A. The Deleterious Effect of Metabolic Acidosis on Nutritional Status of Hemodialysis Patients. Saudi J. Kidney Dis. Transplant. 2011;22:1149–1154.
    1. Wu D.Y., Shinaberger C.S., Regidor D.L., McAllister C.J., Kopple J.D., Kalantar-Zadeh K. Association between serum bicarbonate and death in hemodialysis patients: Is it better to be acidotic or alkalotic? Clin. J. Am. Soc. Nephrol. 2006;1:70–78. doi: 10.2215/CJN.00010505.
    1. Bommer J., Locatelli F., Satayathum S., Keen M.L., Goodkin D.A., Saito A., Akiba T., Port F.K., Young E.W. Association of Predialysis Serum Bicarbonate Levels with Risk of Mortality and Hospitalization in the Dialysis Outcomes and Practice Patterns Study (DOPPS) Am. J. Kidney Dis. 2004;44:661–671. doi: 10.1016/S0272-6386(04)00936-9.
    1. Misra M. Pro: Higher serum bicarbonate in dialysis patients is protective. Nephrol. Dial. Transplant. 2016;31:1220–1224. doi: 10.1093/ndt/gfw259.
    1. Kang S.S., Chang J.W., Park Y. Nutritional Status Predicts 10-Year Mortality in Patients with End-Stage Renal Disease on Hemodialysis. Nutrients. 2017;9:399. doi: 10.3390/nu9040399.
    1. James G., Jackson H. European Guidelines for the Nutritional Care of Adult Renal Patients. EDTNA-ERCA Journal. 2003;29:23–43. doi: 10.1111/j.1755-6686.2003.tb00270.x.
    1. Malaysian Dietetic Association (MDA) Malaysian Medical Nutrition Therapy (MNT) Guidelines for Chronic Kidney Disease. MDA; Kuala Lumpur, Malaysia: 2005.
    1. Cano N., Fiaccadori E., Tesinsky P., Toigo G., Druml W., Kuhlmann M., Mann H., Horl W.H. ESPEN Guidelines on Enteral Nutrition: Adult Renal Failure. Clin. Nutr. 2006;25:295–310. doi: 10.1016/j.clnu.2006.01.023.
    1. Sualaheen A., Khor B.H., Balasubramanian G., Sahathevan S., Ali M.S.M., Narayanan S.S., Chinna K., Daud A.A.M., Khosla P., Karupaiah T. Habitual Dietary Patterns of Patients on Haemodialysis Indicate Nutritional Risk. J. Ren. Nutr. 2020;30:322–332. doi: 10.1053/j.jrn.2019.09.010.
    1. Burrowes J.D., Larive B., Cockram D.B., Dwyer J., Kusek J.W., McLeroy S., Poole D., Rocco M.V. Effects of Dietary Intake, Appetite, and Eating Habits on Dialysis and Non–Dialysis Treatment Days in Hemodialysis Patients: Cross-Sectional Results From the HEMO Study. J. Ren. Nutr. 2003;13:191–198. doi: 10.1016/S1051-2276(03)00069-4.
    1. Harvinder G.H., Chee W.S.S., Karupaiah T., Sahathevan S., Chinna K., Ghazali A., Bavanandan S., Goh B.L. Comparison of malnutrition prevalence between haemodialysis and continuous ambulatory peritoneal dialysis patients: A cross-sectional study. Malays J. Nutr. 2013;19:271–283.
    1. Ichikawa Y., Hiramatsu F., Hamada H., Sakai A., Hara K., Kogirima M., Kawahara K., Minakuchi J., Kawashima S., Yamamoto S. Effect of protein and energy intakes of body composition in non-diabetic maintenance hemodialysis patients. J. Nutr. Sci. Vitaminol. 2007;53:410–418. doi: 10.3177/jnsv.53.410.
    1. Moreira A.C., Carolino E., Domingos F., Gaspar A., Ponce P., Camili M.E. Nutritional status influences generic and disease-specific quality of life measures in haemodialysis patients. Nutr. Hosp. 2013;28:951–957.
    1. Rocco M.V., Paranandi L., Burrowes J.D., Cockram D.B., Dwyer J.T., Kusek J.W., Leung J., Makoff R., Maroni B., Poole D. Nutritional Status in the HEMO Study Cohort at baseline. Am. J. Kidney Dis. 2002;39:245–256. doi: 10.1053/ajkd.2002.30543.
    1. Sahathevan S., Se C.H., Ng S.H., Chinna K., Harvinder G.S., Chee W.S.S., Goh B.L., Halim A.G., Bavanandan S., Ghazali A., et al. Assessing protein energy wasting in a Malaysian haemodialysis population using self-reported appetite rating: A cross sectional study. BMC Nephrol. 2015;16:99. doi: 10.1186/s12882-015-0073-x.
    1. Adanan N.I.H., Ali M.S.M., Lim J.H., Zakaria N.F., Lim C.T.S., Yahya R., Gafr A.H.A., Karupaiah T., Daud Z.A.M. Investigating Physical and Nutritional Changes During Prolonged Intermittent Fasting in Hemodialysis Patients: A Prospective Cohort Study. J. Ren. Nutr. 2020;30:e15–e26. doi: 10.1053/j.jrn.2019.06.003.
    1. Arslan Y., Kiziltan G. Nutrition-Related Cardiovascular Risk Factors in Hemodialysis Patients. J. Ren. Nutr. 2010;20:185–192. doi: 10.1053/j.jrn.2009.08.008.
    1. Chauveau P., Grigaut E., Kolko A., Wolff P., Combe C., Aparicio M. Evaluation of nutritional status in patients with kidney disease: Usefulness of dietary recall. J. Ren. Nutr. 2007;17:88–92. doi: 10.1053/j.jrn.2006.10.015.
    1. Johansson L., Hickson M., Brown E.A. Influence of Psychosocial Factors on the Energy and Protein Intake of Older People on Dialysis. J. Ren. Nutr. 2013;23:348–355. doi: 10.1053/j.jrn.2013.02.009.
    1. Kalantar-Zadeh K., Kopple J.D., Deepak S., Block D., Block G. Characteristics of Hemodialysis Patients as Obtained by Food Frequency Questionnaire. J. Food Intake Ren. Nutr. 2002;12:17–31. doi: 10.1053/jren.2002.29598.
    1. Kim H., Lim H., Choue R. A Better Diet Quality is Attributable to Adequate Energy Intake in Hemodialysis Patients. Clin. Nutr. Res. 2015;4:46–55. doi: 10.7762/cnr.2015.4.1.46.
    1. Morais A.A.C., Silva M.A.T., Faintuch J., Vidigal E.J., Costa R.A., Lyrio D.C., Trindade C.R., Pitanga K.K. Correlation of nutritional status and food intake in hemodialysis patients. Clinics. 2005;60:185–192. doi: 10.1590/S1807-59322005000300002.
    1. Shapiro B.B., Bross R., Morrison G., Kalantar-Zadeh K., Kopple J.D. Self-Reported Interview-Assisted Diet Records Underreport Energy Intake in Maintenance Hemodialysis Patients. J. Ren. Nutr. 2015;25:357–363. doi: 10.1053/j.jrn.2014.12.004.
    1. Vijayan M., Abraham G., Alex M.E., Vijayshree N., Reddy Y., Fernando E., Mather M., Nair S., Yuvaraj A. Nutritional status in stage V dialyzed patient versus CKD patient on conservative therapy across different economic status. Ren. Fail. 2014;36:384–389. doi: 10.3109/0886022X.2013.872570.
    1. Stumvoll M., Meyer C., Perriello G., Kreider M., Welle S., Gerich J. Human kidney and liver gluconeogenesis: Evidence for organ substrate selectivity. Am. J. Physiol. 1998;274:E817–E826. doi: 10.1152/ajpendo.1998.274.5.E817.
    1. Antunes A.A., Delatim Vannini F., de Arruda Silveira L.V., Martin L.C., Barretti P., Caramori J.C. Influence of protein intake and muscle mass on survival in chronic dialysis patients. Ren. Fail. 2010;32:1055–1059. doi: 10.3109/0886022X.2010.510233.
    1. Pauzi F.A., Sahathevan S., Khor B.H., Narayanan S.S., Zakaria N.F., Abas F., Karupaiah T., Daud Z.A.M. Exploring Metabolic Signature of Protein Energy Wasting in Hemodialysis Patients. Metabolites. 2020;10:291. doi: 10.3390/metabo10070291.
    1. Gordon A., editor. Food Safety and Quality Systems in Developing Countries. Academic Press; San Diego, CA, USA: 2015. Biochemistry of Hypoglycin and Toxic Hypoglycemic Syndrome; pp. 47–61.
    1. Zimmerer J.L., Leon J.B., Covinsky K.E., Desai U., Sehgal A.R. Diet Monotony as a Correlate of Poor Nutritional Intake Among Hemodialysis Patients. J. Ren. Nutr. 2003;13:72–77. doi: 10.1053/jren.2003.50025.
    1. Kalantar-Zadeh K., Block G., McAllister C.J., Humphreys M.H., Kopple J. Appetite and inflammation, nutrition, anemia and clinical outcome in hemodialysis patients. Am. J. Clin. Nutr. 2004;80:299–307. doi: 10.1093/ajcn/80.2.299.
    1. Beberashvili I., Sinuani I., Azar A., Yasur H., Shapiro G., Feldman L., Averbukh Z., Weissgarten J. IL-6 Levels, Nutritional Status, and Mortality in Prevalent Hemodialysis Patients. Clin. J. Am. Soc. Nephrol. 2011;6:2253–2263. doi: 10.2215/CJN.01770211.
    1. Lynch K.E., Lynch R., Curhan G.C., Brunelli S.M. Altered Taste Perception and Nutritional Status among Hemodialysis Patients. J. Ren. Nutr. 2013;23:288–295. doi: 10.1053/j.jrn.2012.08.009.
    1. Ekramzadeh M., Mazloom Z., Jafari P., Ayatollahi M., Sagheb M.M. Major Barriers Responsible for Malnutrition in Hemodialysis Patients: Challenges to Optimal Nutrition. Nephro-Urol. Mon. 2014;6:e23158. doi: 10.5812/numonthly.23158.
    1. Bossola M., Luciani G., Rosa F., Tazza L. Appetite and Gastrointestinal Symptoms in Chronic Hemodialysis Patients. J. Ren. Nutr. 2011;21:448–454. doi: 10.1053/j.jrn.2010.09.003.
    1. Tavares A.P.D.S.R., Mafra D., Leal V.O., Gama M.D.S., Vieira R.M.M.F., Brum I.S.D.C., Borges N.A., Silva A.A. Zinc Plasma Status and Sensory Perception in Nondialysis Chronic Kidney Disease Patients. J. Ren. Nutr. 2020 doi: 10.1053/j.jrn.2020.05.012.
    1. Ronveaux C.C., Tomé D., Raybould H.E. Glucagon-Like Peptide 1 Interacts with Ghrelin and Leptin to Regulate Glucose Metabolism and Food Intake through Vagal Afferent Neuron Signaling. J Nutr. 2015;145:672–680. doi: 10.3945/jn.114.206029.
    1. Vanitha R.N., Kavimani S., Soundararajan P., Chamundeeswari D., Kannan G., Rengarajan S. Ghrelin and its Association with Nutritional and Inflammatory Status of Patients on Maintenance Hemodialysis in a South Indian Tertiary Care Hospital. Ann. Med. Health Sci. Res. 2016;6:146–155. doi: 10.4103/2141-9248.183937.
    1. Klok M.D., Jakobsdottir S., Drent M.L. The role of leptin and ghrelin in the regulation of food intake and body weight in humans: A review. Obes. Rev. 2007;8:21–34. doi: 10.1111/j.1467-789X.2006.00270.x.
    1. Ko Y.T., Lin Y.L., Kuo C.H., Lai Y.H., Wang C.H., Hsu B.G. Low serum leptin levels are associated with malnutrition status according to malnutrition-inflammation score in patients undergoing chronic hemodialysis. Hemodial. Int. 2020;24:221–227. doi: 10.1111/hdi.12806.
    1. Montazerifar F., Karajibani M., Gorgij F., Akbari O. Malnutrition Markers and Serum Ghrelin Levels in Hemodialysis Patients. Int. Sch. Res. Not. 2014;2014:765895. doi: 10.1155/2014/765895.
    1. Kara E., Ahbap E., Sahutoglu T., Sakaci T., Basturk Y., Koc Y., Sevinc M., Akgol C., Ucar Z.A., Kayalar A.O., et al. Elevated serum leptin levels are associated with good nutritional status in non-obese chronic hemodialysis patients. Clin. Nephrol. 2015;83:147–153. doi: 10.5414/CN108409.
    1. Mafra D., Guebre-Egziabher F., Cleaud C., Arkouche W., Mialon A., Drai J., Fouque D. Obestatin and ghrelin interplay in hemodialysis patients. Nutrition. 2010;26:1100–1104. doi: 10.1016/j.nut.2009.09.003.
    1. Iikuni N., Lam Q.L.K., Lu L., Matarese G., Cava A.L. Leptin and Inflammation. Curr. Immunol. Rev. 2008;4:70–79. doi: 10.2174/157339508784325046.
    1. Molfino A., Kaysen G.A., Chertow G.M., Doyle J., Delgado C., Dwyer T., Laviano A., Fanelli F.R., Johansen K.L. Validating Appetite Assessment Tools Among Patients Receiving Hemodialysis. J. Ren. Nutr. 2016;26:103–110. doi: 10.1053/j.jrn.2015.09.002.
    1. Perez-Fontan M., Cordido F., Rodriguez-Carmona A., Peteiro J., Garcia-Naveiro R., Garcia-Buela J. Plasma ghrelin levels in patients undergoing haemodialysis and peritoneal dialysis. Nephrol. Dial. Transplant. 2004;19:2095–2100. doi: 10.1093/ndt/gfh313.
    1. Kursat S., Colak H.B., Toraman A., Tekçe H., Ulman C., Bayturan O. Relationship of insulin resistance in chronic haemodialysis patients with inflammatory indicators, malnutrition, echocardiographic parameters and 24 hour ambulatory blood pressure monitoring. Scand. J. Urol. Nephrol. 2010;44:257–264. doi: 10.3109/00365591003733682.
    1. Mak R.H.K., DeFronzo R.A. Glucose and insulin metabolism in urea. Nephron. 1992;61:377–382. doi: 10.1159/000186953.
    1. Siew E.D., Ikizler T.A. Insulin Resistance and Protein Energy Metabolism in Patients with Advanced Chronic Kidney Disease. Semin. Dial. 2010;23:378–382. doi: 10.1111/j.1525-139X.2010.00763.x.
    1. O’Sullivan A.J., Kelly J.J. Insulin resistance and protein catabolism in non-diabetic hemodialysis patients. Kidney Int. 2007;71:98–100. doi: 10.1038/sj.ki.5002045.
    1. Hung A.M., Ikizler T.A. Factors Determining Insulin Resistance in Chronic Hemodialysis Patients. Lipid Disord. Metab. 2011;171:127–134.
    1. Liao M.T., Sung C.C., Hung K.C., Wu C.C., Lo L., Lu K.C. Insulin Resistance in Patients with Chronic Kidney Disease. J. Biomed. Biotechnol. 2012;2012:691369. doi: 10.1155/2012/691369.
    1. Grosjean F., Esposito P., Maccarrone R., Libetta C., Canton A.D., Rampino T. RBP4: A Culprit for Insulin Resistance in End Stage Renal Disease That Can Be Cleared by Hemodiafiltration. BioMed Res. Int. 2017;2017:7270595. doi: 10.1155/2017/7270595.
    1. Yang Q., Graham T.E., Mody N. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature. 2005;436:356–362. doi: 10.1038/nature03711.
    1. Wolf G. Serum retinol-binding protein: A link between obesity, insulin resistance, and type 2 diabetes. Nutr. Rev. 2007;65:251–256. doi: 10.1111/j.1753-4887.2007.tb00302.x.
    1. Lecker S.H., Goldberg A.L., Mitch W.E. Protein Degradation by the Ubiquitin-Proteasome Pathway in Normal and Disease States. J. Am. Soc. Nephrol. 2006;17:1807–1819. doi: 10.1681/ASN.2006010083.
    1. Rasic-Milutinovic Z., Perunicic-Pekovic G., Ristic-Medic D., Popovic T., Glibetic M., Djuric D.M. Insulin resistance and chronic inflammation are associated with muscle wasting in end-stage renal disease patients on hemodialysis. Gen. Physiol. Biophys. 2009;28:184–189.
    1. Hui-Ling W., Ting-Ting D., Shi L., Ye X., Jun T., Wei-Feng H., Jin-Yuan Z. Muscle mass loss and intermuscular lipid accumulation were associated with insulin resistance in patients receiving hemodialysis. Chin. Med. J. 2013;126:4612–4617.
    1. Koo J.R., Yoon J.W., Kim S.G., Lee Y.K., Oh K.H., Kim G.H., Kim H.J., Chae D.W., Noh J.W., Lee S.K., et al. Association of Depression with Malnutrition in Chronic Hemodialysis Patients. Am. J. Kidney Dis. 2003;41:1037–1042. doi: 10.1016/S0272-6386(03)00201-4.
    1. Choi M.J., Seo J.W., Yoon J.W., Lee S.K., Kim S.J., Lee Y.K., Noh J.W., Koo J.R. The Malnutrition-Inflammation-Depression- Arteriosclerosis Complex Is Associated with an Increased Risk of Cardiovascular Disease and All-Cause Death in Chronic Hemodialysis Patients. Nephron Clin. Pract. 2012;122:44–52. doi: 10.1159/000348509.
    1. Ogrizovic S.S., Jovanovic D., Dopsaj V., Radovic M., Sumarac Z., Bogavac S.N., Stosovic M., Stanojevic M., Nesic V. Could depression be a new branch of MIA syndrome? Clin. Nephrol. 2008;71:164–172. doi: 10.5414/CNP71164.
    1. Lopes M.B., Silva L.F., Lopes G.B., Penalva M.A., Matos C.M., Robinson B.M., Lopes A.A. Additional Contribution of the Malnutrition–Inflammation Score to Predict Mortality and Patient-Reported Outcomes as Compared With Its Components in a Cohort of African Descent Hemodialysis Patients. J. Ren. Nutr. 2017;27:45–52. doi: 10.1053/j.jrn.2016.08.006.
    1. Natashia D., Yen M., Chen H.M., Fetzer S.J. Self-Management Behaviors in Relation to Psychological Factors and Interdialytic Weight Gain among Patients Undergoing Hemodialysis in Indonesia. J. Nurs. Scholarsh. 2019;51:417–426. doi: 10.1111/jnu.12464.
    1. Kiajamali M., Hosseini M., Estebsari F., Nasiri M., Ashktorab T., Abdi A., Mahmoudi A., Salimi A., Abadi A. Correlation between social support, self-efficacy and health-promoting behavior in hemodialysis patients hospitalized in Karaj in 2015. Electron. Physician. 2017;9:4820–4827. doi: 10.19082/4820.
    1. Kara B., Caglar K., Kilic S. Nonadherence with diet and fluid restrictions and perceived social support in patients receiving hemodialysis. J. Nurs. Scholarsh. 2007;39:243–248. doi: 10.1111/j.1547-5069.2007.00175.x.
    1. Dilek E., Kocaoz S. Adherence to diet and fluid restriction of individuals on hemodialysis treatment and affecting factors in Turkey. Jpn. J. Nurs. Sci. 2015;12:113–123.
    1. Anees M., Batool S., Imtiaz M., Ibrahim M. Socio-economic factors affecting quality of life of hemodialysis patients and its effects on mortality. Pak. J. Med Sci. 2018;34:811–816. doi: 10.12669/pjms.344.15284.
    1. Lopes A.A., Elder S.J., Ginsberg N., Andreucci V.E., Cruz J.M., Fukuhara S., Mapes D.L., Saito A., Pisoni R.L., Saran R., et al. Lack of appetite in haemodialysis patients—Associations with patient characteristics, indicators of nutritional status and outcomes in the international DOPPS. Nephrol. Dial. Transplant. 2007;22:3538–3546. doi: 10.1093/ndt/gfm453.
    1. Untas A., Thumma J., Rascle N., Rayner H., Mapes D., Lopes A.A., Fukuhara S., Akizawa T., Morgenstern H., Robinson B.M., et al. The Associations of Social Support and Other Psychosocial Factors with Mortality and Quality of Life in the Dialysis Outcomes and Practice Patterns Study. Clin. J. Am. Soc. Nephrol. 2011;6:142–152. doi: 10.2215/CJN.02340310.
    1. Clark-Cutaia M.N., Sevick M.A., Thurheimer-Cacciotti J., Hoffman L.A., Snetselaar L., Burke L.E., Zickmund S.L. Perceived Barriers to Adherence to Hemodialysis Dietary Recommendations. Clin. Nurs. Res. 2018;28:1009–1029. doi: 10.1177/1054773818773364.
    1. Freitas A.T.V., Vaz I.M.F., Ferraz S.F., Peixoto M.R.G., Campos M.I.V.M. Prevalence of malnutrition and associated factors in hemodialysis patients. Rev. Nutr. 2014;27:357–366. doi: 10.1590/1415-52732014000300009.
    1. Gebrie M.H., Ford J.A. Depressive symptoms and dietary nonadherence among end stage renal disease patients undergoing hemodialysis therapy: Systematic review. BMC Nephrol. 2019;20:429. doi: 10.1186/s12882-019-1622-5.
    1. Bujang M.A., Musa R., Liu W.J., Chew T.F., Lim C.T.S., Morad Z. Depression, anxiety and stress among patients with dialysis and the association with quality of life. Asian J. Psychiatr. 2015;18:49–52. doi: 10.1016/j.ajp.2015.10.004.
    1. Koo J.R., Yoon J.Y., Joo M.H., Lee H.S., Oh J.E., Kim S.G., Seo J.W., Kim H.J., Noh J.W., Lee S.K., et al. Treatment of Depression and Effect of Antidepression Treatment on Nutritional Status in Chronic Hemodialysis Patients. Am. J. Med. Sci. 2005;329:1–5. doi: 10.1097/00000441-200501000-00001.
    1. Cukor D., Cohen S.D., Peterson R.A., Kimmel P.L. Psychosocial Aspects of Chronic Disease: ESRD as a Paradigmatic Illness. J. Am. Soc. Nephrol. 2007;18:3042–3055. doi: 10.1681/ASN.2007030345.
    1. Liu X., Yang X., Yao L., Zhang Q., Sun D., Zhu X., Xu T., Liu Q., Wang L. Prevalence and related factors of depressive symptoms in hemodialysis patients in northern China. BMC Psychiatr. 2017;17:128. doi: 10.1186/s12888-017-1294-2.
    1. Huang B., Lai B., Xu L., Wang Y., Cao Y., Yan P., Chen J. Low employment and low willingness of being reemployed in Chinese working-age maintained hemodialysis patients. Ren. Fail. 2017;39:607–612. doi: 10.1080/0886022X.2017.1361834.
    1. Tangvoraphonkchai K., Davenport A. Extracellular Water Excess and Increased Self-Reported Fatigue in Chronic Hemodialysis Patients. Ther. Apher. Dial. 2018;22:152–159. doi: 10.1111/1744-9987.12648.
    1. Hatthakit U. Lived experiences of patients on hemodialysis: A meta-synthesis. Nephrol. Nurs. J. 2012;39:295–304.
    1. Helanterä I., Haapio M., Koskinen P., Grönhagen-Riska C., Finne P. Employment of Patients Receiving Maintenance Dialysis and After Kidney Transplant: A Cross-sectional Study from Finland. Am. J. Kidney Dis. 2012;59:700–706. doi: 10.1053/j.ajkd.2011.08.025.
    1. Jules D.E.S., Woolf K., Pompeii M.L., Sevick M.A. Exploring Problems in Following the Hemodialysis Diet and Their Relation to Energy and Nutrient Intakes: The BalanceWise Study. J. Ren. Nutr. 2016;26:118–124. doi: 10.1053/j.jrn.2015.10.002.
    1. Painter P., Roshanravan B. The association of physical activity and physical function with clinical outcomes in adults with chronic kidney disease. Curr. Opin. Nephrol. Hypertens. 2013;22:615–623. doi: 10.1097/MNH.0b013e328365b43a.
    1. Painter P. Physical functioning in end-stage renal disease patients: Update 2005. Hemodial. Int. 2005;9:218–235. doi: 10.1111/j.1492-7535.2005.01136.x.
    1. Bossola M., Marzetti E., Stasio E.D., Monteburini T., Cenerelli S., Mazzoli K., Parodi E., Sirolli V., Santarelli S., Ippoliti F., et al. Prevalence and associated variables of postdialysis fatigue: Results of a prospective multicenter study. Nephrology. 2018;23:552–558. doi: 10.1111/nep.13059.
    1. Bonner A., Wellard S., Caltabiano M. The impact of fatigue on daily activity in people with chronic kidney disease. J. Clin. Nurs. 2010;19:3006–3015. doi: 10.1111/j.1365-2702.2010.03381.x.
    1. Tchape O.D.M., Tchapoga Y.B., Atuhaire C., Priebe G., Cumber S.N. Physiological and psychosocial stressors among hemodialysis patients in the Buea Regional Hospital, Cameroon. Pan Afr. Med. J. 2018;30:49.
    1. Abdulan I.M., Onofriescu M., Stefaniu R., Mastaleru A., Mocanu V., Alexa I.D., Covic A. The predictive value of malnutrition for functional and cognitive status in elderly hemodialysis patients. Int. Urol. Nephrol. 2019;51:155–162. doi: 10.1007/s11255-018-2000-0.

Source: PubMed

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren